TF
WST icon

TIAA FSB’s West Pharmaceutical WST Stock Holding History

TIAA FSB’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$293K Buy
765
+21
+3% +$7.5K ﹤0.01% 488
2023
Q1 		$258K Buy
+744
New +$217K ﹤0.01% 506
2022
Q3 		– Sell
-795
Closed -$240K – 601
2022
Q2 		$240K Buy
+795
New +$259K ﹤0.01% 527

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

TIAA FSB's WST Position: Q2 2023 in Review

TIAA FSB increased its West Pharmaceutical (WST) stake by 2.8% in Q2 2023, buying an estimated $7.5K and bringing the position to 765 shares worth $293K. The position accounts for ﹤0.01% of the portfolio, ranked #488.

TIAA FSB first reported a position in WST in Q2 2022 and has held it in 3 quarters since. 734 funds tracked by Wall St. Rank hold WST as of Q2 2023.

  • TIAA FSB held 765 shares of West Pharmaceutical worth $293K as of Q2 2023.
  • TIAA FSB bought 21 West Pharmaceutical shares in Q2 2023, an estimated $7.5K.
  • West Pharmaceutical made up ﹤0.01% of TIAA FSB's portfolio in Q2 2023, its #488 holding.
  • TIAA FSB first reported a position in West Pharmaceutical in Q2 2022 and has held it in 3 quarters since.
  • 734 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on TIAA FSB's 13F filing for Q2 2023, filed 31 Jul 2023.